Clinical Trial: Study on the correlation between anlotinib concentration and efficacy and adverse reactions in patients with bone and soft tissue sarcoma (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the correlation between anlotinib concentration and efficacy and adverse reactions in patients with bone and soft tissue sarcoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135853

Registration Time: 2026/11/03

Type: Observational study

Primary Sponsor: Shanghai Sixth People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344307

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the correlation between anlotinib concentration and efficacy and adverse reactions in patients with bone and soft tissue sarcoma (China)